Exousia Bio, Inc. Operating Expenses
Exousia Bio, Inc. (LMMY) reported Operating Expenses of $206.71 thousand for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-06-16.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-06-16
- Exousia Bio, Inc. operating expenses for the quarter ending 2026-02-28 was $0.00, a 100.00% decline year-over-year.
- Exousia Bio, Inc. operating expenses for the quarter ending 2025-11-30 was $174.90K, a 2405.33% increase year-over-year.
- Exousia Bio, Inc. operating expenses for the quarter ending 2025-08-31 was $31.81K, a 293.15% increase year-over-year.
- Exousia Bio, Inc. operating expenses for the quarter ending 2025-05-31 was $21.21K.
- Exousia Bio, Inc. operating expenses for fiscal 2025 was $31.84K, a 13.42% increase from fiscal 2024.
- Exousia Bio, Inc. operating expenses for fiscal 2024 was $28.08K, a 50.24% decline from fiscal 2023.
- Exousia Bio, Inc. operating expenses for fiscal 2023 was $56.42K.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 4 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2026-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-16 | $174.90K 10-Q · filed 2026-06-16 | $174.90K derived: sum of 2 quarters · filed 2026-06-16 | $206.71K 10-Q · filed 2026-06-16 | $227.92K derived: sum of 4 quarters · filed 2026-06-16 | ||
| 2025-11-30 | $174.90K 10-Q · filed 2026-03-17 | $206.71K 10-Q · filed 2026-03-17 | $227.92K derived: sum of 3 quarters · filed 2026-03-17 | $251.75K derived: sum of 4 quarters · filed 2026-03-17 | |||
| 2025-08-31 | $31.81K 10-Q · filed 2025-11-17 | $53.02K derived: sum of 2 quarters · filed 2025-11-17 | $76.85K derived: sum of 3 quarters · filed 2025-11-17 | $83.83K derived: sum of 4 quarters · filed 2026-03-17 | |||
| 2025-05-31 | $21.21K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-17 | $45.04K derived: sum of 2 quarters · filed 2025-10-17 | $52.02K derived: sum of 3 quarters · filed 2026-03-17 | $31.84K 10-K · filed 2025-10-17 | |||
| 2025-02-28 | $23.83K 10-Q · filed 2025-04-24 | $6.98K 10-Q · filed 2026-06-16 | $30.81K derived: sum of 2 quarters · filed 2026-03-17 | $10.63K 10-Q · filed 2026-06-16 | $35.59K 10-Q · filed 2025-04-24 | $38.67K derived: sum of 4 quarters · filed 2026-03-17 | |
| 2024-11-30 | $6.98K 10-Q · filed 2026-03-17 | $10.63K 10-Q · filed 2026-03-17 | $14.85K derived: sum of 3 quarters · filed 2026-03-17 | $23.54K derived: sum of 4 quarters · filed 2026-03-17 | |||
| 2024-08-31 | $8.09K 10-Q · filed 2025-11-17 | $8.09K 10-Q · filed 2024-10-11 | $7.86K derived: sum of 2 quarters · filed 2025-11-17 | $16.56K derived: sum of 3 quarters · filed 2025-11-17 | $24.01K derived: sum of 4 quarters · filed 2025-11-17 | ||
| 2024-05-31 | -$228.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-17 | $8.47K derived: sum of 2 quarters · filed 2025-10-17 | $15.91K derived: sum of 3 quarters · filed 2025-10-17 | $28.08K 10-K · filed 2025-10-17 | |||
| 2024-02-29 | $8.70K 10-Q · filed 2025-04-24 | $16.14K derived: sum of 2 quarters · filed 2025-04-24 | $28.30K 10-Q · filed 2025-04-24 | ||||
| 2023-11-30 | $7.45K 10-Q · filed 2025-01-10 | $19.61K 10-Q · filed 2025-01-10 | |||||
| 2023-08-31 | $12.16K 10-Q · filed 2024-10-11 | ||||||
| 2023-05-31 | $56.42K 10-K · filed 2024-08-30 |